BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21910594)

  • 1. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue.
    Oka H; Miyauchi M; Furusho H; Nishihara T; Takata T
    J Periodontol; 2012 Apr; 83(4):506-13. PubMed ID: 21910594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells.
    Nukaga J; Kobayashi M; Shinki T; Song H; Takada T; Takiguchi T; Kamijo R; Hasegawa K
    J Periodontol; 2004 Feb; 75(2):249-59. PubMed ID: 15068113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N; Maeda H; Yoshimine Y; Akamine A
    Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinobacillus actinomycetemcomitans lipopolysaccharide activates matrix metalloproteinase-2 and increases receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells.
    Tiranathanagul S; Yongchaitrakul T; Pattamapun K; Pavasant P
    J Periodontol; 2004 Dec; 75(12):1647-54. PubMed ID: 15732867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
    Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
    J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts.
    Shoji M; Tanabe N; Mitsui N; Tanaka H; Suzuki N; Takeichi O; Sugaya A; Maeno M
    Life Sci; 2006 Mar; 78(17):2012-8. PubMed ID: 16289620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2).
    Mayahara K; Yamaguchi A; Takenouchi H; Kariya T; Taguchi H; Shimizu N
    Arch Oral Biol; 2012 Oct; 57(10):1377-84. PubMed ID: 22884709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis.
    Inubushi T; Kawazoe A; Miyauchi M; Yanagisawa S; Subarnbhesaj A; Chanbora C; Ayuningtyas NF; Ishikado A; Tanaka E; Takata T
    Arch Oral Biol; 2014 Feb; 59(2):226-32. PubMed ID: 24370195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
    Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
    J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis.
    Yamano E; Miyauchi M; Furusyo H; Kawazoe A; Ishikado A; Makino T; Tanne K; Tanaka E; Takata T
    Lab Invest; 2010 Aug; 90(8):1236-46. PubMed ID: 20421871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boric acid inhibits alveolar bone loss in rats by affecting RANKL and osteoprotegerin expression.
    Sağlam M; Hatipoğlu M; Köseoğlu S; Esen HH; Kelebek S
    J Periodontal Res; 2014 Aug; 49(4):472-9. PubMed ID: 24033134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells.
    Wang GF; Wu ZF; Wan L; Wang QT; Chen FM
    Pharmacology; 2006; 77(2):71-7. PubMed ID: 16636611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminothiazoles inhibit osteoclastogenesis and PGE
    Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-bound CD40 ligand on T cells from mice injected with lipopolysaccharide accelerates lipopolysaccharide-induced osteoclastogenesis.
    Yokoyama M; Ukai T; Ayon Haro ER; Kishimoto T; Yoshinaga Y; Hara Y
    J Periodontal Res; 2011 Aug; 46(4):464-74. PubMed ID: 21521224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
    Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N
    Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.
    Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG
    Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of receptor activator of nuclear factor kappa B ligand relates to inflammatory bone resorption, with or without occlusal trauma, in rats.
    Yoshinaga Y; Ukai T; Abe Y; Hara Y
    J Periodontal Res; 2007 Oct; 42(5):402-9. PubMed ID: 17760817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.